Skip to main content
. 2015 Sep 14;55:381–396. doi: 10.1007/s40262-015-0325-8
Our data support a clinically relevant role of hepatic transporters in darunavir pharmacokinetics.
We successfully approximated the increase in darunavir exposure mediated by ritonavir co-administration and the decrease in darunavir exposure during pregnancy, using physiologically based pharmacokinetic modelling.